CompoAtlas

Digebiane RFx

Food supplement declared in France, declaration No 2023-2-639

Digebiane RFx is a food supplement declared in France. Status: retiré du marché le 31 October 2025. 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
PILEJE
Status
Retiré du marché le 31 October 2025
Form
Comprimé
Daily dose
4
Directions for use
1 comprimé à croquer, après les principaux repas ou au coucher (4 comprimés par jour)
Not recommended for (according to the manufacturer)
Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Utilisation prolongée
Objectives stated by the manufacturer (these are not authorised claims)
Digestion

Declaration 268898, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Melissa officinalis L.FeuilleExtrait sec hydroalcoolique600 mg
Glycyrrhiza glabra L.RacineExtrait sec hydroalcoolique150 mg

Other active ingredients

NamePer day
Pectinesnot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Carbonate de calciumCalcium2,500 mg800 mg
Bicarbonate de sodiumSodiumpas de limite (données insuffisantes)aucune dose fixée
RiboflavineVitamine B2 (riboflavine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011

Additives

E953, E401, E470b, E960, E955

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Conseils d'utilisation complet : 1 comprimé à croquer, après les principaux repas et au coucher (4 comprimés par jour). Espacer la prise d’au moins 2 h avec celle d’autres traitements par voie orale.Précautions d'emploi : Déconseillé aux enfants et aux femmes enceintes ou allaitantes. Ne pas utiliser pendant plus de 6 semaines sans avis médical. Une consommation excessive peut avoir des effets laxatifs.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.